Similar articles

• Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer.

  Tamjid B, Phan P, John T, Mitchell P, Gan H. Tamjid B, et al. Head Neck. 2017 Aug;39(8):1544-1549. doi: 10.1002/hed.24751. Epub 2017 Jun 7. Head Neck. 2017. PMID: 28593651
• Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites.

  Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Erkal HS, et al. J Clin Oncol. 2001 Mar 1;19(5):1358-62. doi: 10.1200/JCO.2001.19.5.1358. J Clin Oncol. 2001. PMID: 11230479
• Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.

  Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K. Morimoto H, et al. World J Gastroenterol. 2017 Feb 14;23(6):1051-1058. doi: 10.3748/wjg.v23.i6.1051. World J Gastroenterol. 2017. PMID: 28246479 Free PMC article.
• [The indication of panendoscopy in the search for synchronous and metachronous head and neck cancer].

  Dulguerov N, Dulguerov P. Dulguerov N, et al. Rev Med Suisse. 2013 Oct 2;9(400):1770, 1772-4. Rev Med Suisse. 2013. PMID: 24187750 Review. French.
• Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung.

  Licciardello JT, Spitz MR, Hong WK. Licciardello JT, et al. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):467-76. doi: 10.1016/0360-3016(89)90096-5. Int J Radiat Oncol Biol Phys. 1989. PMID: 2674075 Review.